U.S. markets closed

Absci Corporation (ABSI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.6500+0.1200 (+4.74%)
At close: 04:00PM EST
2.6700 +0.02 (+0.75%)
After hours: 05:32PM EST

Absci Corporation

18105 SE Mill Plain Boulevard
Vancouver, WA 98683
United States
360 949 1041

Full Time Employees211

Key Executives

NameTitlePayExercisedYear Born
Mr. Sean McClainFounder, CEO, Pres & Director1.02MN/A1991
Dr. Sarah Korman J.D., Ph.D.Chief Legal Officer & Corp. Sec.591.47kN/A1979
Mr. Gregory T. Schiffman CPA, CPA, MBAChief Financial OfficerN/AN/A1957
Todd Bedrick CPASr. VP & Chief Accounting OfficerN/AN/AN/A
Mr. Jack GoldChief Marketing OfficerN/AN/AN/A
Melissa Patterson Ph.D.Chief of StaffN/AN/AN/A
Ms. Denise DettoreChief People OfficerN/AN/AN/A
Dr. Andreas Busch Ph.D.Chief Innovation OfficerN/AN/A1963
Jonathan Eads M.S.Sr. VP of InformaticsN/AN/AN/A
Thomas Wrona J.D., Ph.D.Sr. VP of Intellectual PropertyN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Corporate Governance

Absci Corporation’s ISS Governance QualityScore as of November 28, 2022 is 9. The pillar scores are Audit: 10; Board: 7; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.